|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
Director |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
539,056 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,131,096 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
786,589 |
|
|
Total
Value |
$65,069,946 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-34.0%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-10 |
474,994 |
2024-05-10 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
Director |
2023-11-07 |
7,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
850 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 22 of 34
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-06-03 |
4 |
D |
$90.00 |
$597,600 |
D/D |
(6,640) |
378,584 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-06-02 |
4 |
D |
$90.72 |
$602,381 |
D/D |
(6,640) |
226,924 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-12-26 |
4 |
AS |
$48.38 |
$338,633 |
D/D |
(7,000) |
171,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-12-26 |
4 |
OE |
$12.99 |
$90,930 |
D/D |
7,000 |
180,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-13 |
4 |
AS |
$68.12 |
$479,720 |
D/D |
(7,000) |
88,101 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-16 |
4 |
OE |
$12.99 |
$349,247 |
I/I |
7,000 |
25,609 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-02-18 |
4 |
OE |
$26.49 |
$185,430 |
D/D |
7,000 |
302,552 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-02-18 |
4 |
AS |
$85.08 |
$595,560 |
D/D |
(7,000) |
295,552 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-02-19 |
4 |
AS |
$83.58 |
$585,060 |
D/D |
(7,000) |
295,552 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-02-19 |
4 |
OE |
$26.49 |
$185,430 |
D/D |
7,000 |
302,552 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-03-11 |
4 |
AS |
$77.68 |
$543,760 |
D/D |
(7,000) |
295,652 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-03-11 |
4 |
OE |
$26.49 |
$185,430 |
D/D |
7,000 |
302,652 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-03-12 |
4 |
OE |
$26.49 |
$185,430 |
D/D |
7,000 |
302,652 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-03-12 |
4 |
AS |
$77.10 |
$539,700 |
D/D |
(7,000) |
295,652 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-10-29 |
5 |
GA |
$0.00 |
$0 |
D/D |
7,011 |
233,168 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-10-29 |
5 |
GD |
$0.00 |
$0 |
I/I |
7,011 |
36,184 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-13 |
4 |
GA |
$0.00 |
$0 |
I/I |
7,064 |
20,609 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,064 |
90,101 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-05-31 |
4 |
OE |
$17.33 |
$128,641 |
D/D |
7,423 |
240,987 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-05-31 |
4 |
AS |
$88.29 |
$655,377 |
D/D |
(7,423) |
233,564 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-05-01 |
4 |
AS |
$36.00 |
$275,069 |
D/D |
(7,453) |
18,667 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2009-06-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
59,440 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2010-05-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
94,067 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-05-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
131,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Business Officer |
|
2012-05-12 |
5 |
D |
$38.00 |
$297,160 |
D/D |
(7,820) |
149,446 |
0 |
- |
|
850 Records found
|
|
Page 22 of 34 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|